黄葵胶囊联合氯沙坦对慢性肾炎患者小管功能保护作用的临床观察.pdf

5o/l5?T54邢null丽nullnull赵石磊nullnull王德润nullnull赵琳琳nullnull解汝娟nullnullnullnullW:DSvBD/=Snull(W:null150001)nullnullYTnullnull?/lo/#%h/Kn%h,5%h*1hUaea/1ZEbM,/l5?/#hZTs1,51s,s,-3-a-3-$rs1,0,XL/#%hzrT,5o/l5?TSB9bZE1null5null1#/lo/,Snull=SnullI/#hF1992M6pES,M-1570W,YK；a?re,?；0.5g/24hnullU2.5g/24h；60ml/minbl2009M52009M11#,sF,vF50,323,o27；F50,326,o24bFYaM-fM,V1b2nullSnull?/lo%h；#,0PV35rTD；P；ia7a#/d?%haY3i%h；Unull2.5g/24h；null133nullmol/L；M-15/70；(o；V8X0FsV；*Ep%；T%；Pa0hN；F6B5b3nullZEnullvF50?aaB,iN$Fo(s0K3)50mg/Q,1Q,*g；F5vF$F5(0vzK3)2.5g/Q,3Q,VgbFYVJaBeX5d510mg,1Q/d,e130/80mmHg/；BR40mg,1Q/d；iaab4null_SnullLK8,L-a2a4a8_24hUaU%9(URBC)a/?(BUNaScr)a(Alb)a(TGaTC)a?(SGPT)#null2-MG(ELISAE,SN?FD/SM-11SN)aNAG(1E,-76003_N,k44)b5nullrSnullA:24hUhnull50%；r:24hUhnull25%；r:U9(h9Fb6nulld9ZEnull(nullxnulls)VU,-T1t_5Z_bnullnullT1nullFBfnullvF#F(ez,a%eh,B,?CAQ,b2nullF3S#null2-MGaNAGHWMfnullnV1bV1nullF_SMnull(nullxnulls)FYAlb24hU(mg)BUN(mmol/L)Scr(nullmol/L)RBCvFFL-40.16null5.781.89null0.436.04null2.5689.56null10.453.67null6.232null41.16null5.451.76null0.435.98null2.4587.42null10.753.02null5.434null43.16null5.751.21null0.34null6.03null2.7888.42null10.752.80null6.128null45.16null5.850.98null0.21null5.89null2.5488.41null9.42null1.80null6.26L-39.46null5.421.95null0.256.12null2.4689.23null10.473.46null6.362null42.43null5.741.71null0.456.05null2.2587.45null9.41null3.34null5.244null44.16null5.781.20null0.24null5.89null2.6388.45null10.542.68null6.258null45.16null5.460.78null0.12*null5.78null2.5887.46null10.851.78null6.20FYSGPT(U/L)TG(mmol/L)TC(mmol/L)null2-MG(nullg/L)NAGU/(g.cr)vFFL-30.67null7.242.11null1.235.24null2.870.61null1.2152.34null21.232null31.38null6.242.01null1.015.10null2.250.58null1.3147.24null19.344null28.68null8.171.89null1.304.56null1.890.50null1.2340.56null21.63null8null30.25null6.231.78null0.98null4.57null2.01null0.47null1.24null39.75null16.23nullL-31.67null6.262.13null0.975.34null2.260.57null1.2357.14null20.352null30.23null6.362.00null1.025.01null2.150.50null1.2151.23null21.234null30.67null7.191.78null0.784.87null1.890.46null1.1340.34null18.698null29.28null6.291.66null0.65*null4.24null1.25*null0.34null1.21*null26.27null12.24*nullnull:vF1,*P0.05；L-1,nullP0.05null72nullnullnullnullnullnullnullnullnullnullnullnullnullnullSD/h2011M1121nullCJITWN,January2011,Vo.l12,No.1nullnull3nullrnullnV2bV2nullFr1null()FYnArr9rq(%)vF50925160.68F50142880.84*null:vF1,*P0.05)nullnullU/#hKnB,vU%93a9F7/lo2,lhvU51-?,/l5%,/l5%3b/UaU1VC,8CSDnullnullanullnullanull%enullS,h/,C,A=,E|,PhfQ%4,Va/b51s,SnullAnull,e,a/abC0Z,-L51s58,aa-3-a-3$a%,bAhT4b4|%f?,8AfQaFUh#h1Tb5L,ARBV0oTvF,5oTF,TAUFqa9rqa24hUaanull2-MGaNAG(vF,4U5/#hL+5r,OQ,4U5?AU,A/l5?,/?ZT,r,wbnullInullnullD1.,S.5vIgA/h5.LD5,2009,9(3):34-35.2.WheelerDC.Oxidationoflowdensitylipoproteinbymesangialcellsmanypromoteglomerularinjury.KidneyInt,1994,45(6):1628-1636.3.ZagerRA.Myoglobindepletesrenaladeninenucleotidepoolsinthepresenceandabsenceofshock.KidneyIn,t1991,39(1):111-119.4.,TV,.5l4,/lo/54.CD,2005,14(11):1429-1430.(l:2010-09-01null:2010-10-28)5/v9%FP21VrY邱振宇nullnull韩亚荣nullnullnullaDBD/=Snull(null121001)nullnull/lo(glomerulosclerosis,GS)/h1hVCbV,9%F(proliferatingcellnuclearantigen,PCNA)TB%9S?rQ/#%9,iO/MB13bP21XKW%e,V?PCNAVr,%9sb-0GSr(X,7D0/h*,/#h,/lo,?Z,7/?,4/h3i,3iHWbLy/,)5/v/lo/l5W%PCNA#/l5WP21VrY,7w/loT#V?bZE1nullLsFnullb)3-rBSDv24,8(200null20)g,aDL4,LV|:SCXK()2003-00070bs3F:F(/F),F,vF,F8bLWvSR!,1J1,i19null22null,MA50%65%b2nullynullLFaFvF(vP/Mmb-FYSEQZE,1(Z08,Mg),1a40.9%3bF)ZE/F,im?7S1Q5(0)2g/kg(i1g/ml3)9b3null4S3.1null24hUaU_null24v24hUaUb10v|4m,l_(Scr)aU(BUN)bH)Fv,M|/,4%:%A(100mlc:10mlabZ5mla95%Y?85ml)%,!b3.2nullF_null/FS%aaFM2nullm,!-H(HE)-k